Author

Ebrahimi M

Royan - Cited by 2,802

Biography

Marzieh Ebrahimi received her B.Sc. in filed of cell and Molecular Biology from department of Biology at Tehran University in 1996, master’s degree and PhD in Medical Immunology form faculty of medicine at Tarbiat Modares University in 2000 and 2007, with focus on tumor therapy by herbal component (as Master thesis) and differentiation and activation of DCs from hematopoietic stem cells (as PhD thesis). Dr. Ebrahimi was joined to department of stem cells at Royan Institute in 2003 as a researcher fellow. After completing her PhD in 2007, 
Title
Cited by
Year
Engineered tumor-derived extracellular vesicles: potentials in cancer immunotherapy
A Taghikhani, F Farzaneh, F Sharifzad, S Mardpour, M Ebrahimi, ...Frontiers in immunology 11, 221, 2020202
70
2020
Potential theranostics of circulating tumor cells and tumor-derived exosomes application in colorectal cancer
S Vafaei, R Roudi, Z Madjd, AR Aref, M EbrahimiCancer cell international 20, 1-15, 2020202
24
2020
HSP70/IL-2 treated NK cells effectively cross the blood brain barrier and target tumor cells in a rat model of induced glioblastoma multiforme (GBM)
F Sharifzad, S Mardpour, S Mardpour, E Fakharian, A Taghikhani, ...International journal of molecular sciences 21 (7), 63, 2020202
22
2020
Salinomycin-loaded injectable thermosensitive hydrogels for glioblastoma therapy
M Norouzi, J Firouzi, N Sodeifi, M Ebrahimi, DW MillerInternational Journal of Pharmaceutics 598, 120316, 2021202
17
2021
Low expression of Talin1 is associated with advanced pathological features in colorectal cancer patients
S Vafaei, L Saeednejad Zanjani, Z Habibi Shams, M Naseri, F Fattahi, ...Scientific Reports 10 (1), 17786, 2020202
16
2020
Comparative phenotypic characterization of human colostrum and breast milk-derived stem cells
N Goudarzi, R Shabani, M Ebrahimi, A Baghestani, E Dehdashtian, ...Human Cell 33, 308-317, 2020202
16
2020
Pluripotent stem cells: cancer study, therapy, and vaccination
M Barati, M Akhondi, NS Mousavi, N Haghparast, A Ghodsi, H Baharvand, ...Stem Cell Reviews and Reports, 1-18, 2021202
14
2021
A dielectrophoresis-based microfluidic system having double-sided optimized 3D electrodes for label-free cancer cell separation with preserving cell viability
V Varmazyari, H Habibiyan, H Ghafoorifard, M Ebrahimi, S Ghafouri-FardScientific Reports (1), 100, 2022202
12
2022
Long-Term Inhibition of Notch in A-375 Melanoma Cells Enhances Tumor Growth Through the Enhancement of AXIN1, CSNK2A3, and CEBPA2 as Intermediate …
F Keyghobadi, M Mehdipour, V Nekoukar, J Firouzi, A Kheimeh, ...Frontiers in oncology , 531, 2020202
10
2020
Overcoming the UCB HSCs–Derived NK cells Dysfunction through Harnessing RAS/MAPK, IGF-1R and TGF-β Signaling Pathways
A Shokouhifar, G Anani Sarab, M Yazdanifar, M Fereidouni, M Nouri, ...Cancer Cell International 21 (1), 298, 2021202
10
2021
An integrated analysis to predict micro‐RNAs targeting both stemness and metastasis in human gastric cancer
M Azimi, M Totonchi, M Rahimi, J Firouzi, P Sahranavard, ...Journal of Gastroenterology and Hepatology 36 (2), 436-445, 2021202
10
2021
Wnt5A modulates integrin expression in a receptor-dependent manner in ovarian cancer cells
V Azimian-Zavareh, Z Dehghani-Ghobadi, M Ebrahimi, K Mirzazadeh, ...Scientific Reports 11 (1), 5885, 2021202
6
2021
NK cell upraise in the dark world of cancer stem cells
A Shokouhifar, J Firouzi, M Nouri, GA Sarab, M EbrahimiCancer Cell International 21 (1), 1-1, 2021202
5
2021
Combination of SB431542, Chir9901, and Bpv as a novel supplement in the culture of umbilical cord blood hematopoietic stem cells
Combination of SB43142, Chir9901, and Bpv as a novel supplement in the culture of umbilical cord blood hematopoietic stem cellsM Zarrabi, E Afzal, MH Asghari, M EbrahimiStem Cell Research & Therapy 11 (1), 1-9, 2020202
5
2020
Topical umbilical cord serum for corneal epithelial defects after diabetic vitrectomy
S Moradian, M Ebrahimi, A Kanaani, A Faramarzi, S SafiJournal of Ophthalmic & Vision Research 1 (2), 160, 2020202
5
2020
Hsp70, in combination with IL-15 and PD-1 blocker, interferes with the induction of cytotoxic NK cells in relapsed acute myeloid leukemia patients
J Firouzi, A Hajifathali, M Azimi, N Parvini, F Ghaemi, NS Asl, AAH Asl, ...Cell Journal (Yakhteh) 25 (2), 92, 20220
3
2023
A microfluidic device for label-free separation sensitivity enhancement of circulating tumor cells of various and similar size
V Varmazyari, H Ghafoorifard, H Habibiyan, M Ebrahimi, S Ghafouri-FardJournal of Molecular Liquids 49, 118192, 2022202
3
2022